Clinical Trials in Detroit

Showing 1561-1580 of 19,719 trials

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

NCT04158336

This is a Phase 1 open-label, multicenter study of ZN-c3 (also known as Azenosertib) monotherapy which consists of Dose Escalation, a Food Effect Cohort, and Dose Expansion.

Solid Tumor

K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc274 participantsStarted Nov 2019

Tucson, Arizona, United States • Newport Beach, California, United States • Chicago, Illinois, United States +5 more locations

RECRUITINGPhase 1/2< 1 mile

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts)

B-cell MalignancyMarginal Zone LymphomaFollicular Lymphoma+6 more

BeOne Medicines614 participantsStarted Sep 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +117 more locations

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Find Trials by Condition in Detroit

A Study of DF6002 Alone and in Combination With Nivolumab

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae

HCMR Re-Imaging Study

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Study of DF1001 in Patients With Advanced Solid Tumors

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

PRISM Intervention Study

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.